Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

HIV infection and COVID-19 death: a population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform
Krishnan Bhaskaran, Christopher T. Rentsch, Brian MacKenna, et al.
The Lancet HIV (2020) Vol. 8, Iss. 1, pp. e24-e32
Open Access | Times Cited: 422

Showing 1-25 of 422 citing articles:

Epidemiology and outcomes of COVID-19 in HIV-infected individuals: a systematic review and meta-analysis
Paddy Ssentongo, Emily S. Heilbrunn, Anna E. Ssentongo, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 279
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial
John Frater, Katie Ewer, Ane Ogbe, et al.
The Lancet HIV (2021) Vol. 8, Iss. 8, pp. e474-e485
Open Access | Times Cited: 234
Overview of SARS-CoV-2 infection in adults living with HIV
Juan Ambrosioni, José Luís Blanco, Juliana Reyes‐Urueña, et al.
The Lancet HIV (2021) Vol. 8, Iss. 5, pp. e294-e305
Open Access | Times Cited: 182
Interrelations between COVID-19 and other disorders
Amin Gasmi, Massimiliano Peana, Lyudmila Pivina, et al.
Clinical Immunology (2020) Vol. 224, pp. 108651-108651
Open Access | Times Cited: 171
Risk factors for COVID-19-related in-hospital mortality in a high HIV and tuberculosis prevalence setting in South Africa: a cohort study
Waasila Jassat, Cheryl Cohen, Stefano Tempia, et al.
The Lancet HIV (2021) Vol. 8, Iss. 9, pp. e554-e567
Open Access | Times Cited: 158
Pre-existing health conditions and severe COVID-19 outcomes: an umbrella review approach and meta-analysis of global evidence
Marina Treskova, Laura Haas, Sarah Reda, et al.
BMC Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 157
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in people living with and without HIV in South Africa: an interim analysis of a randomised, double-blind, placebo-controlled, phase 1B/2A trial
Shabir A. Madhi, Anthonet Koen, Alane Izu, et al.
The Lancet HIV (2021) Vol. 8, Iss. 9, pp. e568-e580
Open Access | Times Cited: 149
Relationship of SARS-CoV-2–specific CD4 response to COVID-19 severity and impact of HIV-1 and tuberculosis coinfection
Catherine Riou, Elsa Du Bruyn, Cari Stek, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 12
Open Access | Times Cited: 147
Associations between HIV infection and clinical spectrum of COVID-19: a population level analysis based on US National COVID Cohort Collaborative (N3C) data
Xueying Yang, Jing Sun, Rena C. Patel, et al.
The Lancet HIV (2021) Vol. 8, Iss. 11, pp. e690-e700
Open Access | Times Cited: 140
Disentangling the relative importance of T cell responses in COVID-19: leading actors or supporting cast?
Stephen J. Kent, David S. Khoury, Arnold Reynaldi, et al.
Nature reviews. Immunology (2022) Vol. 22, Iss. 6, pp. 387-397
Open Access | Times Cited: 123
Humoral and Cellular Immune Response Elicited by mRNA Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in People Living With Human Immunodeficiency Virus Receiving Antiretroviral Therapy Based on Current CD4 T-Lymphocyte Count
Andrea Antinori, Stefania Cicalini, Silvia Meschi, et al.
Clinical Infectious Diseases (2022) Vol. 75, Iss. 1, pp. e552-e563
Open Access | Times Cited: 114
COVID-19 in immunocompromised populations: implications for prognosis and repurposing of immunotherapies
Jason D. Goldman, Philip C. Robinson, Thomas S. Uldrick, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 6, pp. e002630-e002630
Open Access | Times Cited: 107
Immunogenicity to COVID-19 mRNA vaccine third dose in people living with HIV
Alessandra Vergori, Alessandro Cozzi Lepri, Stefania Cicalini, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 92
Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapy
Zabrina L. Brumme, Francis Mwimanzi, Hope R. Lapointe, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 84
Current and Emerging Knowledge in COVID-19
Yeon Joo Jeong, Yu Mi Wi, Hyunjin Park, et al.
Radiology (2023) Vol. 306, Iss. 2
Open Access | Times Cited: 77
Assessment of Clinical Outcomes Among Children and Adolescents Hospitalized With COVID-19 in 6 Sub-Saharan African Countries
Jean B. Nachega, Nadia A. Sam‐Agudu, Rhoderick Machekano, et al.
JAMA Pediatrics (2022) Vol. 176, Iss. 3, pp. e216436-e216436
Open Access | Times Cited: 75
Risk Factors of Severe COVID-19: A Review of Host, Viral and Environmental Factors
Levente Zsichla, Viktor Müller
Viruses (2023) Vol. 15, Iss. 1, pp. 175-175
Open Access | Times Cited: 71
Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19
Christiana Kartsonaki, J. Kenneth Baillie, Noelia García Barrio, et al.
International Journal of Epidemiology (2023) Vol. 52, Iss. 2, pp. 355-376
Open Access | Times Cited: 49
Disparities in COVID-19 mortality amongst the immunosuppressed: A systematic review and meta-analysis for enhanced disease surveillance
Meredith Leston, Willam Elson, José M. Ordóñez‐Mena, et al.
Journal of Infection (2024) Vol. 88, Iss. 3, pp. 106110-106110
Open Access | Times Cited: 19
Persistent SARS-CoV-2 infection and intra-host evolution in association with advanced HIV infection
Farina Karim, MYS Moosa, BI Gosnell, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 102
COVID-19 Vaccine Hesitancy among French People Living with HIV
Alexandre Vallée, Erwan Fourn, C. Majerholc, et al.
Vaccines (2021) Vol. 9, Iss. 4, pp. 302-302
Open Access | Times Cited: 101
Impact of COVID-19 on people living with HIV: A review
Sandeep Prabhu, Selvamuthu Poongulali, Nagalingeswaran Kumarasamy
Journal of Virus Eradication (2020) Vol. 6, Iss. 4, pp. 100019-100019
Open Access | Times Cited: 93
Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study
Daniel K. Nomah, Juliana Reyes‐Urueña, Yesika Díaz, et al.
The Lancet HIV (2021) Vol. 8, Iss. 11, pp. e701-e710
Open Access | Times Cited: 91
Risk of adverse coronavirus disease 2019 outcomes for people living with HIV
Maya M. Mellor, Anne C. Bast, Nicholas Jones, et al.
AIDS (2021) Vol. 35, Iss. 4, pp. F1-F10
Open Access | Times Cited: 89
Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV
Aljawharah Alrubayyi, Ester Gea‐Mallorquí, Emma Touizer, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 89
Page 1 - Next Page

Scroll to top